Sales of Bulgaria's drugmaker Sopharma fall 17% y/y in January 2012.

By bne IntelliNews February 3, 2012
The sales revenue of leading local pharmaceutical producer Sopharma decreased by 17% y/y in January, including 9% y/y exports decline and 37% y/y contraction of the domestic market sales, the company said in a note, posted on the website of the local stock exchange. The company explains the results with the unfavourable weather conditions. The non-consolidated total revenues of Sopharma increased by 2.8% to BGN 245.1mn (EUR 125.3mn) in 2011, including sales growth of 1.5% y/y to more than 94% of total revenues. Domestic sales (up by 3.4% y/y) accounted for 31.2% of all sales as compared to 30.2% in 2010. Exports sales declined by 0.9% y/y. The net non-consolidated profit of the company added 0.3% y/y to BGN 40.7mn (EUR 20.8mn) last year. Sopharma said that the economic and political problems in Europe, the echo of the economic crisis and some administrative issues have reduced the growth rate last year.

Related Articles

EC urges Bulgaria to comply with EU rules on free movement of capital.

The EC has sent a reasoned opinion to Bulgaria over failure to comply with EU rules on the free movement of capital, the EC said on its website. The privatisation act in Bulgaria introduces ... more

Govt seeks delay of antitrust rules violation procedure against Bulgaria.

Bulgaria will be seeking an extension of the court procedure filed by the EC against the country over irregularities found in the assignment of digital broadcast spectrum, transport minister ... more

Bulgarians hold EUR 100mn in deposits in Cyprus.

Bulgarian individuals and companies hold EUR 100mn in Cypriot banks according to ECB data, BTA reported quoting Reuters. The largest EU depositors in the crisis-hit country are Greece with EUR ... more

Notice: Undefined index: subject_id in /var/www/html/application/controllers/IndexController.php on line 335
Dismiss